Patient-Centered Advances in the Management of Crohn’s Disease

Jointly sponsored by the Medical Education Collaborative, Inc (MEC) and Princeton CME

Purpose Statement

This activity is designed to educate pharmacists, gastroenterologist nurses, and case managers on the clinical and economic burden of Crohn’s disease and the effect of this disease on patient quality of life. Through the utilization of available treatment strategies—including conventional pharmacologic and surgical approaches, as well as emerging biologic therapies—disease remission may be induced and maintained, resulting in optimal patient outcomes.

Target Audience

This activity is designed for pharmacists, gastroenterologist nurses, and case managers.

Learning Objectives

After completing this activity, participants should be able to:

Discuss the clinical and economic burden of Crohn’s disease, including the effect of disease on patient quality of life
Outline the benefits and limitations of conventional pharmacologic and surgical approaches for the treatment of Crohn’s disease
Evaluate the potential impact of emerging biologic therapies for the management of refractory Crohn’s disease
Utilize available treatment strategies to induce and maintain remission of Crohn’s disease for optimal patient outcomes

Credit Eligibility

To be eligible for documentation of credit, participants must participate in the full educational activity—including Question and Answer session—complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants seeking CPE or CCM credit who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. All participants seeking CNE credit who successfully complete the post-test and evaluation form will receive documentation of credit by mail within 6 weeks.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release date: July 11, 2008; Expiration date: July 11, 2009

Estimated time to complete: 1 hour

There is no fee associated with this activity.

Lecture Components

The presentation slides, Q&A session, post-test, and evaluation form are available as a click through via the menu at the top of each page of this educational activity.

CNE Accreditation

Medical Education Collaborative, Inc (MEC) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity for 1.0 contact hour is provided by MEC.

MEC is approved by the California Board of Registered Nursing, Provider Number 129909 for 1.0 contact hour.

For questions regarding the ANCC accreditation of this activity, please contact MEC at 866-420-3252.

CPE Accreditation

Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UPN 452-999-08-019-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity sponsored or cosponsored by Princeton CME may contact the Assistant Director of Continuing Education in writing. The Assistant Director of Continuing Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Director of Continuing Education may be made for a second level of review.

Independent Clinical Reviewer: Brian Behm, MD, MS, Assistant Professor of Internal Medicine, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, Virginia

Case Manager Accreditation

This activity is approved for 1 hour of continuing education credit for case managers by the Commission for Case Manager Certification (CCMC).

Grant Support

Supported by an educational grant from Abbott Laboratories.

Participating Faculty

Sharon Dudley-Brown, PhD, FNP-BC
Assistant Professor
Schools of Medicine and Nursing
Johns Hopkins University
Baltimore, Maryland

Randolph V. Fugit, PharmD, BCPS
Internal Medicine Clinical Specialist
Denver Veterans Affairs Medical Center
Adjoint Assistant Professor, Pharmacy Practice
University of Colorado Health Sciences Center
Denver, Colorado

Jonathan A. Leighton, MD
Professor of Medicine
Chair, Division of Gastroenterology and Hepatology
Mayo Clinic
Scottsdale, Arizona

Nancy Skinner, RN, CCM
Principal Consultant
Riverside HealthCare Consulting
Adjunct Faculty
University of Southern Indiana
Whitwell, Tennessee

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of Medical Education Collaborative, Inc (MEC) and Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of MEC and Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Dudley-Brown: Speaker—Crohn’s and Colitis Foundation of America
Dr. Fugit: Consultant—Pfizer, Inc; Grant/research support—Pfizer, Inc; Speakers bureau—Boehringer Ingelheim Pharmaceuticals, Cubist Pharmaceuticals, Pfizer, Inc, sanofi-aventis U.S.
Dr. Leighton: Consultant— Given Imaging, NPS Pharmaceuticals, Procter & Gamble; Grant/research support—Abbott Laboratories, Bristol-Myers Squibb Company, Given Imaging, Otsuka America Pharmaceuticals, Procter & Gamble
Ms. Skinner: Speakers bureau—Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb Company, Daiichi Sankyo, Forest Pharmaceuticals, Inc, Pfizer, Inc, Roche Diagnostics, sanofi-aventis U.S.; Advisory board—Boehringer Ingelheim Pharmaceuticals
Dr. Behm disclosed no relevant financial relationships with any commercial interests.

Planning Committee employees of MEC, the accredited provider for this activity; Randy Robbin and John Savage, Princeton CME; and Jessica Brown, Kristin Dickie, and Mary Johnson, Princeton Media Communications have disclosed that they have no relevant financial relationships with any commercial interest.

MEC and Princeton CME require faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentations.

The following off-label/unapproved drugs or devices are discussed: 5-aminosalicylic acids, prednisone, prednisolone, immunomodulators, metronidazole, and ciprofloxacin in the treatment of Crohn’s disease.

Privacy Policy

Medical Education Collaborative, Inc (MEC) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MEC and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

MEC and Princeton CME maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Publisher’s Note

The opinions expressed in this educational activity are those of the presenters and are not attributable to the sponsor or the publisher, editor, or advisory board of Medical Education Collaborative, Inc (MEC) and Princeton Media Communications. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.